Matthew E. Falagas
Impact in
- Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria
- Applied Microbiology and Biotechnology top 0.01%
- Antibiotic Use and Resistance
Papers in
- Epidemiology 191
- Pneumonia and Respiratory Infections 66
- Urinary Tract Infections Management 42
-
- Antibiotic Resistance in Bacteria 138
- Co-authors
- Konstantinos Z. Vardakas (94 shared papers)Drosos E. Karageorgopoulos (69 shared papers)Γεώργιος Παππάς (19 shared papers)Petros I. Rafailidis (91 shared papers)Eleni Pitsouni (14 shared papers)Argyris Michalopoulos (55 shared papers)George Malietzis (3 shared papers)Ioannis A. Bliziotis (46 shared papers)
- Journals
- International Journal of Antimicrobial Agents (49 papers)European Journal of Clinical Microbiology & Infectious Diseases (33 papers)Expert Review of Anti-infective Therapy (21 papers)PLoS ONE (20 papers)Journal of Antimicrobial Chemotherapy (19 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Matthew E. Falagas
586 papers receiving 47.9k citations
Matthew E. Falagas's Hit Papers
Peers
Comparison fields: 5 of 231
- Molecular Medicine 15.1k
- Applied Microbiology and Biotechnology 3.5k
- Endocrinology 4.0k
- Critical Care and Intensive Care Medicine 2.3k
- Clinical Biochemistry 2.7k
Countries citing papers authored by Matthew E. Falagas
This map shows the geographic impact of Matthew E. Falagas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Falagas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Falagas more than expected).
Fields of papers citing papers by Matthew E. Falagas
This network shows the impact of papers produced by Matthew E. Falagas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Falagas. The network helps show where Matthew E. Falagas may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Falagas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 592 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Hit paper breakdown → | 2011 | 10394 |
| 2 | Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses Hit paper breakdown → | 2007 | 3529 |
| 3 | Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis Hit paper breakdown → | 2009 | 833 |
| 4 | Obesity and infection Hit paper breakdown → | 2006 | 638 |
| 5 | Fosfomycin Hit paper breakdown → | 2016 | 457 |
| 6 | Deaths Attributable to Carbapenem-ResistantEnterobacteriaceaeInfections Hit paper breakdown → | 2014 | 412 |
| 7 | Comparison of SCImago journal rank indicator with journal impact factor Hit paper breakdown → | 2008 | 407 |
| 8 | 2009 | 402 | |
| 9 | 2008 | 396 | |
| 10 | 2008 | 352 | |
| 11 | Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis Hit paper breakdown → | 2015 | 334 |
| 12 | 2006 | 328 | |
| 13 | 2007 | 320 | |
| 14 | 2007 | 309 | |
| 15 | 2008 | 294 | |
| 16 | 2010 | 290 | |
| 17 | 2007 | 289 | |
| 18 | 2009 | 285 | |
| 19 | 2012 | 280 | |
| 20 | 2009 | 276 |
About Matthew E. Falagas
Matthew E. Falagas is a scholar working on Epidemiology, Molecular Medicine, Infectious Diseases, Pharmacology and Surgery, having authored 592 papers that have together received 49.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (138 papers), Antibiotics Pharmacokinetics and Efficacy (81 papers), Pneumonia and Respiratory Infections (66 papers), Nosocomial Infections in ICU (43 papers), Urinary Tract Infections Management (42 papers), Antimicrobial Resistance in Staphylococcus (42 papers), Antibiotic Use and Resistance (41 papers) and Bacterial Identification and Susceptibility Testing (30 papers). The work is most often cited by research in Molecular Medicine (15.1k citations), Applied Microbiology and Biotechnology (3.5k citations), Endocrinology (4.0k citations), Critical Care and Intensive Care Medicine (2.3k citations) and Clinical Biochemistry (2.7k citations). Matthew E. Falagas has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Konstantinos Z. Vardakas, Drosos E. Karageorgopoulos, Γεώργιος Παππάς, Petros I. Rafailidis, Eleni Pitsouni, Argyris Michalopoulos, George Malietzis, Ioannis A. Bliziotis, George Samonis and Alkiviadis Vatopoulos. Their work appears in journals such as International Journal of Antimicrobial Agents, European Journal of Clinical Microbiology & Infectious Diseases, Expert Review of Anti-infective Therapy, PLoS ONE and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.